Roche

Roche dumps early pipeline efforts as sales jump

5 days ago   |   Fierce Biotech

Big Pharma giant Roche has quietly cut a series of early- to midstage experimental drugs as it continues the traditional quarterly clear-out.
Read more ...

Led by Gilead Veteran Riva, Glenmark's Ichnos Steps Out on Its Own

Led by Gilead Veteran Riva, Glenmark's Ichnos Steps Out on Its Own

6 days ago   |   Xconomy

Glenmark Pharmaceuticals, which has made generic drugs for about four decades, on Tuesday formally spun off its drug R&D unit as an independent business aiming to advance a...
Read more ...

The $102B club: The top 15 R&D spenders in the global biopharma business - 2019 edition

6 days ago   |   San Diego Biotechnology   |   3 articles

Roche: The pharma giant delivered the blockbusters it had to have, here's the second wave AbbVie: A Phase III derailment costs AbbVie, but a big buyout and recent successes at...
Read more ...

Five Years After Y Combinator First Admits Biotechs, They're Dug In

Five Years After Y Combinator First Admits Biotechs, They're Dug In

12 days ago   |   Xconomy

Five years ago, the big tech incubator Y Combinator started to welcome life sciences companies into its sizable startup classes, which had previously nurtured entrepreneurs in...
Read more ...

ESMO 2019: PARP and Prostate, SeaGen's Win, KRAS Update & More

ESMO 2019: PARP and Prostate, SeaGen's Win, KRAS Update & More

20 days ago   |   Xconomy

The European Society for Medical Oncology meeting has wrapped up in Barcelona, the last major clinical cancer conference until December's annual ASH meeting for blood diseases...
Read more ...

How an arthritis drug from Roche's library could repair damaged hearts

1 month ago   |   Fierce Biotech

Scientists at Vanderbilt University say they've found a potential way to improve the process by which the heart repairs itself after a heart attack, and it comes from an...
Read more ...

Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M

Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M

1 month ago   |   Xconomy   |   3 articles

In the nucleus of human cells sit our chromosomes, comprised mainly of tightly wound DNA. In some cells, however, some pieces of genetic material that exist within the nucleus...
Read more ...

Foghorn and Rgenix nab Agios, Roche veterans as new CMOs

1 month ago   |   Fierce Biotech

Smaller biotechs are continuing their biopharma hiring spree as two startups nab some big names for their aspiring cancer drug research.
Read more ...

Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More

Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More

1 month ago   |   Xconomy

For decades, advanced lung cancer was a quick death sentence. That's no longer a given, thanks in part to the arrival of immunotherapy. If a medical meeting in Barcelona this...
Read more ...

Roche's satralizumab cuts relapse risk in rare disease phase 3

1 month ago   |   Fierce Biotech

In a phase 3 trial of its neuromyelitis optica spectrum disorder treatment satralizumab, Roche linked the anti-IL-6 antibody to a 55% reduction in the risk of relapse, showing...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study

SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study

An experimental breast cancer drug from Seattle Genetics is headed for FDA review after the company reported a pivotal clinical trial met its main goals. The company has been... Read more ...

Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer

Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer

Cancer therapies that harness the immune system don't work for all patients. Verseau Therapeutics aims to bring cancer immunotherapy to more people by targeting a type of... Read more ...

The secret of classic Belgian beers? Medieval super-yeasts

An international team of scientists led by Prof. Kevin Verstrepen and Prof. Steven Maere has discovered that some of the most renowned classic Belgian beers, including Gueuze... Read more ...

Edible grasshoppers can be modified for better fatty acid composition

It is possible to modify the fatty acid composition of edible grasshoppers by adding essential fatty acids in their feed, new research from the University of Eastern Finland... Read more ...

Manager, Engineering - Bachem - Vista, CA

The company provides a full range of services to the pharma and biotech industries. Handle complete project life cycle from design, planning and implementation...From Bachem... Read more ...

Bayer backs off running Casebia JV, as CRISPR Tx takes over management

Three years after Bayer and gene-editing biotech CRISPR Therapeutics joined forces to launch and run Casebia Therapeutics, the German Pharma is now handing over the full reins... Read more ...

Uncovering the principles behind RNA folding

Using high-throughput next-generation sequencing technology, a researcher found similarities in the folding tendencies among a family of RNA molecules called riboswitches... Read more ...

Listening in to how proteins talk and learning their language

A research team has created a third approach to engineering proteins that uses deep learning to distill the fundamental features of proteins directly from their amino acid... Read more ...

Pinpointing biomolecules with nanometer accuracy

Scientists demonstrate a new approach in fluorescence microscopy that can be used to locate individual biomolecules in 3D space with nanometer-scale precision. Read more ...

How the mouse X and Y chromosomes compete with each other to control offspring

New research presents the first demonstration of a specific difference in sperm function associated with sex ratio skewing. Read more ...